InflaRx (IFRX) Long-Term Investments (2016 - 2026)

InflaRx has disclosed Long-Term Investments across 11 years of filings, most recently posting $29.0 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $29.0 million, up 11514.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.0 million (up 11514.96% YoY), and the FY2025 annual result was $35.4 million, up 972.14% from the prior year.
• Long-Term Investments came in at $29.0 million for Q1 2026 at InflaRx, down from $35.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $56.0 million in Q1 2022 to a low of $239668.8 in Q3 2022.
• The 5-year median for Long-Term Investments is $8.6 million (2023), against an average of $17.0 million.
• Across the five-year window, Long-Term Investments sank 99.62% in 2022 and soared 15370.9% in 2025, its largest moves.
• InflaRx's Long-Term Investments stood at $3.0 million in 2022, then surged by 229.1% to $9.7 million in 2023, then sank by 66.07% to $3.3 million in 2024, then soared by 972.14% to $35.4 million in 2025, then declined by 18.02% to $29.0 million in 2026.
• The last three Long-Term Investments figures came in at $29.0 million (Q1 2026), $35.4 million (Q4 2025), and $44.7 million (Q3 2025), per Business Quant data.